ALS2 p.Pro372Arg
c.1115C>G · rs190369242 · VCV241307
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0813 | likely benign |
|---|---|---|
| REVEL | 0.124 | moderately benign-leaning |
| SaProt | LLR -7.28 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.5 | GERP 0.88, phastCons 1 |
| Regional constraint | o/e 0.88 | unconstrained · MANE · 11 kb · p 0.0064 · regional, not allelic |
| Overall | ||
| CADD | 21.4 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Middle Easterngrpmax | 0.578% | 173 |
| South Asian | 0.236% | 423 |
| Remaining individualsnot grpmax-eligible | 0.188% | 533 |
| European (non-Finnish) | 0.154% | 648 |
| Admixed American | 0.0917% | 1,090 |
| African / African-American | 0.032% | 3,122 |
| Ashkenazi Jewishnot grpmax-eligible | 0.0237% | 4,223 |
| Finnishnot grpmax-eligible | 0.00864% | 11,577 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ALS2
- Protein
- p.Pro372Arg
- Coding
- c.1115C>G
- MANE Select
- NM_020919
- dbSNP
- rs190369242
- Type
- single nucleotide variant
- Location
- chr2:201757758 (GRCh38)
- Gene constraint
- LOEUF 0.649 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 74.69
Disease context
ALS2-related disorder — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: amyotrophic lateral sclerosis type 2, juvenilejuvenile primary lateral sclerosisinfantile-onset ascending hereditary spastic paralysishereditary spastic paraplegia
Similar variants
- ALS2 c.1640+1G>A Pathogenic/Likely pathogenic ★★ same condition
- ALS2 c.2580+2T>C Pathogenic ★★ same condition
- ALS2 c.3703-2A>G Pathogenic/Likely pathogenic ★★ same condition
- ALS2 c.4626+1G>A Pathogenic/Likely pathogenic ★★ same condition
- ALS2 p.Ala573Glu Likely pathogenic ★★ same condition
- ALS2 p.Arg1139Ter Pathogenic/Likely pathogenic ★★ same condition
- ALS2 p.Arg1421Ter Pathogenic/Likely pathogenic ★★ same condition
- ALS2 p.Arg1461Ter Pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/als2-p-pro372arg (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown